BORJE S ANDERSSON to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications BORJE S ANDERSSON has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.014
-
Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome. Leukemia. 2008 Feb; 22(2):258-64.
Score: 0.009
-
Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease. Blood. 2000 Jan 01; 95(1):83-9.
Score: 0.005